Filing Details

Accession Number:
0001179110-18-012267
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-18 17:05:48
Reporting Period:
2018-10-16
Accepted Time:
2018-10-18 17:05:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242612 S Roger Newton C/O Esperion Therapeutics Inc.
3891 Ranchero Drive, Suite 150
Ann Arbor MI 48108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-16 9,400 $50.01 589,326 No 4 S Direct
Common Stock Disposition 2018-10-17 12,673 $50.02 576,653 No 4 S Direct
Common Stock Disposition 2018-10-18 100 $50.00 576,553 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2018.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4